Approvals/TGA/VEGZELMA bevacizumab 400 mg/ 16 mL solution for intravenous infusion, vial

Approved

STANDARD

VEGZELMA bevacizumab 400 mg/ 16 mL solution for intravenous infusion, vial

Celltrion Healthcare Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 04c7c6887f7267ce
Product Name: VEGZELMA bevacizumab 400 mg/ 16 mL solution for intravenous infusion, vial
Artg Id: 398632
Artg Name: VEGZELMA bevacizumab 400 mg/ 16 mL solution for intravenous infusion, vial
Sponsor: Celltrion Healthcare Australia Pty Ltd
Company Detail Path: /organization/celltrion-healthcare-australia-pty-ltd
Artg Date: 2023-09-05
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/fe841d546e56b2f4e87fb0adc5a5314e.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/5a6ad54ceab51c192cdc8b8d1a2fe661.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

04c7c6887f7267ce

Type

Standard